Tyra Biosciences, Inc. Common Stock (TYRA) is a publicly traded Healthcare sector company. As of July 28, 2026, TYRA trades at $31.55 with a market cap of $1.82B and a P/E ratio of -15.87. TYRA moved +1.44% today. Year to date, TYRA is +18.14%; over the trailing twelve months it is +180.83%. Its 52-week range spans $6.42 to $40.65. Analyst consensus is strong buy with an average price target of $49.88. Rallies surfaces TYRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TYRA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $31.55 |
| Market Cap | $1.82B |
| P/E Ratio | -15.87 |
| EPS | $-2.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.65 |
| 52-Week Low | $6.42 |
| Volume | 331.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-119.95M |
| Gross Margin | 0.00% |
12 analysts cover TYRA: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $49.88.